| Molecular characterization of mitochondrial apoptosis-inducing factor SA Susin, HK Lorenzo, N Zamzami, I Marzo, BE Snow, GM Brothers, ... Nature 397 (6718), 441-446, 1999 | 5506 | 1999 |
| Bax and adenine nucleotide translocator cooperate in the mitochondrial control of apoptosis I Marzo, C Brenner, N Zamzami, JM Jürgensmeier, SA Susin, HLA Vieira, ... Science 281 (5385), 2027-2031, 1998 | 1575 | 1998 |
| Mitochondrial release of caspase-2 and-9 during the apoptotic process SA Susin, HK Lorenzo, N Zamzami, I Marzo, C Brenner, N Larochette, ... The Journal of experimental medicine 189 (2), 381-394, 1999 | 967 | 1999 |
| The permeability transition pore complex: a target for apoptosis regulation by caspases and Bcl-2–related proteins I Marzo, C Brenner, N Zamzami, SA Susin, G Beutner, D Brdiczka, ... The Journal of experimental medicine 187 (8), 1261-1271, 1998 | 891 | 1998 |
| The apoptosis-necrosis paradox. Apoptogenic proteases activated after mitochondrial permeability transition determine the mode of cell death T Hirsch, P Marchetti, SA Susin, B Dallaporta, N Zamzami, I Marzo, ... Oncogene 15 (13), 1573-1581, 1997 | 683 | 1997 |
| Subcellular and submitochondrial mode of action of Bcl-2-like oncoproteins N Zamzami, C Brenner, I Marzo, SA Susin, G Kroemer Oncogene 16 (17), 2265-2282, 1998 | 621 | 1998 |
| Bcl-2 and Bax regulate the channel activity of the mitochondrial adenine nucleotide translocator C Brenner, H Cadiou, HLA Vieira, N Zamzami, I Marzo, Z Xie, B Leber, ... Oncogene 19 (3), 329-336, 2000 | 514 | 2000 |
| Glutathione depletion is an early and calcium elevation is a late event of thymocyte apoptosis. A Macho, T Hirsch, I Marzo, P Marchetti, B Dallaporta, SA Susin, ... Journal of immunology (Baltimore, Md.: 1950) 158 (10), 4612-4619, 1997 | 407 | 1997 |
| Arsenite induces apoptosis via a direct effect on the mitochondrial permeability transition pore N Larochette, D Decaudin, E Jacotot, C Brenner, I Marzo, SA Susin, ... Experimental cell research 249 (2), 413-421, 1999 | 393 | 1999 |
| Nitric oxide induces apoptosis via triggering mitochondrial permeability transition S Hortelano, B Dallaporta, N Zamzami, T Hirsch, SA Susin, I Marzo, ... FEBS letters 410 (2-3), 373-377, 1997 | 309 | 1997 |
| Role of the mitochondrial permeability transition pore in apoptosis T Hirsch, I Marzo, G Kroemer Bioscience Reports 17 (1), 67-76, 1997 | 276 | 1997 |
| Lonidamine triggers apoptosis via a direct, Bcl-2-inhibited effect on the mitochondrial permeability transition pore L Ravagnan, I Marzo, P Costantini, SA Susin, N Zamzami, PX Petit, ... Oncogene 18 (16), 2537-2546, 1999 | 248 | 1999 |
| Mitochondria in chemotherapy-induced apoptosis: a prospective novel target of cancer therapy D Decaudin, I Marzo, C Brenner, G Kroemer International journal of oncology 12 (1), 141-193, 1998 | 241 | 1998 |
| Cytofluorometric detection of mitochondrial alterations in early CD95/Fas/APO-1-triggered apoptosis of Jurkat T lymphoma cells. Comparison of seven mitochondrion-specific … D Métivier, B Dallaporta, N Zamzami, N Larochette, SA Susin, I Marzo, ... Immunology letters 61 (2-3), 157-163, 1998 | 240 | 1998 |
| Potassium leakage during the apoptotic degradation phase B Dallaporta, T Hirsch, SA Susin, N Zamzami, N Larochette, C Brenner, ... The Journal of Immunology 160 (11), 5605-5615, 1998 | 223 | 1998 |
| Immunogenic cell death and immunotherapy of multiple myeloma A Serrano-del Valle, A Anel, J Naval, I Marzo Frontiers in Cell and Developmental Biology 7, 50, 2019 | 204 | 2019 |
| The thiol crosslinking agent diamide overcomes the apoptosis-inhibitory effect of Bcl-2 by enforcing mitochondrial permeability transition N Zamzami, I Marzo, SA Susin, C Brenner, N Larochette, P Marchetti, ... Oncogene 16 (8), 1055-1063, 1998 | 194 | 1998 |
| Mitochondrial permeability transition in apoptosis and necrosis T Hirsch, SA Susin, I Marzo, P Marchetti, N Zamzami, G Kroemer Cell biology and toxicology 14, 141-145, 1998 | 190 | 1998 |
| Caspases disrupt mitochondrial membrane barrier function I Marzo, SA Susin, PX Petit, L Ravagnan, C Brenner, N Larochette, ... FEBS letters 427 (2), 198-202, 1998 | 189 | 1998 |
| MLL-rearranged acute lymphoblastic leukemias activate BCL-2 through H3K79 methylation and are sensitive to the BCL-2-specific antagonist ABT-199 JM Benito, L Godfrey, K Kojima, L Hogdal, M Wunderlich, H Geng, I Marzo, ... Cell reports 13 (12), 2715-2727, 2015 | 157 | 2015 |